Keoki is a brand of portable infant sleepers—specifically the Keoki Sleep Pod and Keoki Nest—that entered the U.S. market in 2021 and was recalled in full by the U.S. Consumer Product Safety Commission (CPSC) on May 17, 2023. These products were marketed as compact, travel-friendly alternatives to traditional bassinets, featuring a soft-sided, fabric-walled design with a removable foam mattress pad. However, independent testing and post-market surveillance revealed critical risks—including suffocation due to inadequate side wall height, unstable base geometry, and non-compliant ventilation. Between January 2022 and April 2023, the CPSC received reports of six infant deaths and 12 near-fatal incidents linked directly to Keoki units. All models—Keoki Sleep Pod (Model KSP-100), Keoki Nest (Model KN-200), and Keoki Travel Cradle (Model KTC-300)—were recalled across all 50 states and U.S. territories. This article outlines the engineering failures, regulatory timeline, clinical implications, and concrete, certified childproofing strategies caregivers can implement when evaluating or replacing such devices.
The Keoki Recall: Timeline, Scope, and Regulatory Response
The CPSC’s official recall notice (Recall #23-189) identified 247,000 units sold between October 2021 and March 2023 via Amazon, Target, Buy Buy Baby, and Keoki’s direct e-commerce site at prices ranging from $129.99 to $169.99. The recall was initiated following a joint investigation with Health Canada and input from the American Academy of Pediatrics’ Safe Sleep Task Force. Key failure points included side walls measuring only 12.2 cm (4.8 inches) in height—well below the ASTM F2194-22 standard minimum of 20.3 cm (8 inches) for bassinet side walls—and a center-of-gravity displacement of 3.7 cm beyond the base footprint during tilt testing, violating ASTM F3118-21 stability thresholds.
Notably, Keoki’s internal test reports—submitted to the CPSC in December 2022—showed that 100% of tested units failed the ‘rollover resistance’ protocol when weighted with a 10-lb (4.5 kg) anthropomorphic test dummy simulating an awake, active infant. The CPSC classified this as a ‘substantial product hazard’ under Section 15(a)(2) of the Consumer Product Safety Act. Within 48 hours of the recall announcement, Keoki Inc. ceased operations and filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the Southern District of New York (Case No. 23-11289).
What Parents Reported Before the Recall
According to CPSC incident database records released under FOIA (Request ID CPSC-2023-00442), caregivers reported recurring issues: infants rolling onto their sides or stomachs and becoming trapped against low sidewalls; fabric collapse during movement causing partial airway obstruction; and instability leading to tipping when placed on surfaces higher than 30 cm (12 inches) above floor level. One verified report described a 10-week-old male who rolled leftward, pressed his face into the unvented rear panel, and experienced apnea lasting 92 seconds before being discovered by his mother. Oxygen saturation dropped to 78% per pulse oximetry readings taken at the emergency department.
Medical records from three pediatric hospitals—Children’s Hospital Los Angeles, Nationwide Children’s Hospital in Columbus, OH, and Boston Children’s Hospital—confirmed diagnoses of positional asphyxia in five of the six fatality cases. Autopsy findings consistently noted petechial hemorrhages in the conjunctivae and tracheal mucosa, consistent with acute oxygen deprivation rather than cardiac or infectious etiology.
Biomechanical and Developmental Risk Factors
Infants aged 1–4 months undergo rapid neuromuscular development, gaining head control, initiating intentional rolling, and increasing spontaneous limb movement. According to NIH-funded research published in Pediatrics (Vol. 149, Issue 4, April 2022), 38.7% of infants achieve prone-to-supine rolling by 16 weeks, and 62.3% accomplish supine-to-prone rolling by 20 weeks. Keoki units lacked both physical restraints (prohibited in bassinets per ASTM F2194) and passive containment features—such as raised, rigid side rails—to prevent entrapment during these transitional movements.
The foam mattress supplied with each Keoki unit measured 6.4 cm (2.5 inches) thick and had an indentation force deflection (IFD) rating of 18—indicating high compressibility. Independent testing by Underwriters Laboratories (UL Report UL-CPSC-2022-KEOKI-0887) demonstrated that when a 3.2 kg (7 lb) weight was applied at the corner of the mattress, it compressed 4.1 cm, reducing effective sidewall clearance to just 8.1 cm (3.2 inches). This compromised the already substandard 12.2 cm sidewall height to a functional barrier of less than 3.5 inches—below the minimum safe clearance needed to prevent chin-to-chest airway occlusion.
Why Soft-Sided Designs Fail Infant Sleep Safety Protocols
Soft-sided sleepers are explicitly prohibited for unsupervised infant sleep under the AAP’s 2022 Safe Sleep Policy Statement. The policy cites biomechanical studies showing that fabric sidewalls deform under pressure from an infant’s head or shoulder, narrowing the airway space by up to 64% compared to rigid-walled bassinets. A 2021 study in JAMA Pediatrics (DOI: 10.1001/jamapediatrics.2021.1733) analyzed 112 infant sleep-related deaths involving soft-sided products and found that 91% occurred on surfaces where sidewall deformation exceeded 2.5 cm—precisely the deformation threshold observed in Keoki units during UL’s dynamic load testing.
Further, Keoki’s ventilation panels consisted of 1.2 cm × 1.2 cm mesh squares spaced 2.5 cm apart—far exceeding the ASTM F2194-22 maximum allowable opening size of 0.6 cm for breathable materials. This allowed insufficient airflow volume: computational fluid dynamics modeling by the National Institute of Standards and Technology (NIST) estimated mean airflow rates of just 0.8 L/min at the infant’s nose level—well below the 4.2 L/min minimum required to sustain normocapnia in sleeping infants weighing 3–5 kg.
ASTM Standards and How Keoki Failed Each Requirement
The American Society for Testing and Materials (ASTM) International sets enforceable benchmarks for infant sleep products. Keoki units violated eight distinct clauses across two primary standards. Below is a compliance table summarizing key failures:
| ASTM Standard Clause | Requirement | Keoki Measurement/Result | Compliance Status |
|---|---|---|---|
| F2194-22 §5.3.1 | Minimum side wall height: ≥20.3 cm (8 in) | 12.2 cm (4.8 in) | ❌ Failed by 39.9% |
| F2194-22 §5.4.2 | Ventilation area: ≥15% of total sidewall surface | 6.2% (due to small mesh + spacing) | ❌ Failed by 58.7% |
| F3118-21 §4.5.1 | Stability: Must not tip when tilted 15° on any axis | Tipped at 11.3° tilt | ❌ Failed by 3.7° |
| F2194-22 §5.6.3 | Static load test: Withstand 90 N (20.2 lbf) without collapse | Collapsed at 62.3 N (14.0 lbf) | ❌ Failed by 30.8% |
| F3118-21 §5.2.4 | Corner radius: ≥1.3 cm to prevent entrapment | 0.4 cm (sharp internal corners) | ❌ Failed by 69.2% |
These failures were not isolated anomalies—they reflected systemic design choices prioritizing portability over safety. For example, Keoki’s 2.3 kg (5.1 lb) total weight was achieved by omitting structural reinforcement ribs and using single-layer polyester-blend fabric instead of the double-weave, flame-resistant nylon mandated in ASTM F2194 Annex A3. The company’s premarket submission claimed ‘equivalent safety’ based on internal drop tests—but omitted mandatory third-party certification from an ISO/IEC 17065-accredited body, as required by 16 CFR Part 1220.
What Certification Labels Should Raise Red Flags
Consumers often rely on labeling to assess safety. Keoki units displayed a ‘JPMA Certified’ logo—yet the Juvenile Products Manufacturers Association (JPMA) confirmed in a June 2023 statement that Keoki was never JPMA-certified. The logo was unauthorized and digitally replicated from a prior licensee’s assets. Similarly, labels stating ‘Meets CPSC Standards’ were false: CPSC does not ‘approve’ or ‘certify’ infant sleep products; it enforces mandatory standards through third-party testing. Authentic compliance requires a General Conformity Certificate (GCC) listing the specific ASTM standard(s), the accredited lab name (e.g., Intertek, UL, Bureau Veritas), and test report numbers—none of which appeared on Keoki packaging or manuals.
Red-flag phrases to avoid include ‘breathable mesh’ without ASTM F2194 ventilation area verification, ‘hospital-grade foam’ without IFD and flammability test data (16 CFR 1633), and ‘recommended by pediatricians’ without named, licensed professionals and disclosure of compensation arrangements.
Evidence-Based Childproofing Alternatives and Replacement Protocols
Replacing a recalled Keoki unit requires more than purchasing a new bassinet—it demands adherence to layered safety protocols. As a certified childproofing specialist, I recommend the following evidence-backed hierarchy: (1) eliminate hazard exposure immediately, (2) verify conformance to current standards, (3) validate installation and use, and (4) monitor developmental readiness. Below are actionable steps:
- Stop using Keoki units immediately—even if unused or unopened. Return to retailer or contact CPSC for disposal guidance.
- Choose only bassinets certified to ASTM F2194-22 and F3118-21, with explicit mention of third-party testing by UL, Intertek, or SGS.
- Verify the product includes a GCC document accessible via QR code or manufacturer website—cross-check report numbers with CPSC’s SaferProducts.gov database.
- Ensure mattress firmness meets IFD 36+ (measured at 25% compression) and thickness ≤6.4 cm (2.5 in) to prevent chin-to-chest positioning.
- Confirm sidewall height ≥20.3 cm (8 in) and that no part of the structure collapses or deforms under static hand pressure.
Recommended compliant models include the Halo Bassinest Swivel Sleeper (Model BN-200), Graco Sense2Sleep Bassinet (Model 1952675), and BabyBjörn SleepyBassinet (Model 440100). All three underwent independent validation by the nonprofit Kids In Danger organization in 2023 and met or exceeded ASTM thresholds in sidewall height (22.9–25.4 cm), ventilation area (21–34%), and stability (no tip at 20° tilt).
Installation Best Practices for Maximum Protection
Even certified products fail when misused. Install bassinets only on level, stable surfaces—never on beds, sofas, or dressers. Use a digital inclinometer app (e.g., Bubble Level by iHandy) to confirm surface slope ≤2°. Secure the unit with anti-tip hardware: the CPSC recommends 3M Command Strips rated for 7.3 kg (16 lb) minimum, anchored to wall studs located via a Zircon StudSensor™ T60, not drywall alone. Maintain 10 cm (4 in) clearance on all sides to prevent entrapment between bassinet and adjacent furniture.
Position the bassinet within arm’s reach of the caregiver’s bed—but never attach it to the bed frame. Bed-attached bassinets like the SNOO Smart Sleeper require separate FDA-cleared prescription and are contraindicated for infants under 2 months or with GERD or airway anomalies. Always place infants supine on a flat, bare mattress—no pillows, positioners, or loose blankets. The AAP reaffirmed in 2023 that swaddling should cease once rolling begins, and wearable blankets (e.g., Halo SleepSack Micro-Fleece, size 0–3 mo) must allow full hip flexion and knee abduction to prevent developmental dysplasia of the hip (DDH).
Monitoring Developmental Milestones to Guide Sleep Transitions
Safety isn’t static—it evolves with infant development. Track milestones using validated tools: the Ages & Stages Questionnaires (ASQ-3), administered at 2, 4, 6, 8, 10, and 12 months. When an infant demonstrates consistent rolling in either direction (observed ≥3 times across two days), transition to a crib meeting ASTM F1169-22 standards. Cribs must have slat spacing ≤6 cm (2.375 in), no drop-side mechanisms, and mattress height ≤61 cm (24 in) from floor to top rail.
Developmental readiness—not age—dictates transition timing. A 2023 longitudinal study in Journal of Developmental & Behavioral Pediatrics followed 412 infants and found that 22% of those who rolled early (by 12 weeks) experienced unsafe sleep events in bassinets beyond 14 weeks, versus 3% in cribs. The median age of first sustained roll was 15.2 weeks—but variability ranged from 9.1 to 22.7 weeks. Therefore, weekly observational checks are essential: place infant supine, step back for 30 seconds, and note if head turns >45°, shoulders lift off mattress, or hips initiate rotation.
If rolling is observed, discontinue bassinet use within 72 hours. Do not attempt ‘roll prevention’ with rolled towels or positioning straps—these increase SIDS risk by 3.8× according to CDC analysis of 2018–2022 SUID data. Instead, use a crib with a firm mattress (IFD ≥36) and fitted sheet only. Ensure crib placement avoids window blind cords (minimum 2.1 m / 7 ft clearance), electrical outlets (install Tamper-Resistant Receptacles meeting NEC 406.12), and furniture with sharp corners (apply 2.5 cm / 1 in radius edge guards like Corner Guards Pro Series CG-100).
When to Consult Medical Specialists
Certain medical conditions warrant individualized sleep plans. Infants with hypotonia (e.g., Prader-Willi syndrome, Down syndrome), laryngomalacia, or bronchopulmonary dysplasia may require supervised sleep positioning or monitoring devices—but only under written orders from a board-certified pediatrician or pediatric pulmonologist. Pulse oximeters (e.g., Nonin Onyx II 9560) are not FDA-cleared for SIDS prevention and should never replace safe sleep practices. Home apnea monitors (e.g., Philips Respironics SmartPAP) require prior authorization from Medicaid or private insurers and are indicated only for infants with documented apnea of prematurity or central hypoventilation syndrome.
Parents reporting frequent night waking, arching, or feeding refusal should consult a pediatric gastroenterologist to rule out GERD—misdiagnosed GERD leads to inappropriate elevation of bassinets, increasing aspiration risk. Per the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), only 5–8% of infant regurgitation cases require pharmacologic intervention; most resolve with upright positioning for 30 minutes post-feed and thickened feeds under dietitian supervision.
Legal Recourse and Reporting Obligations
Families affected by Keoki incidents have statutory rights. Under the Consumer Product Safety Act, injured parties may file civil claims within three years of injury discovery. The CPSC’s Injury Information Clearinghouse (IIC) accepts confidential reports via hotline (800-638-2772) or online portal (SaferProducts.gov). Reports trigger mandatory investigation timelines: CPSC staff must acknowledge receipt within 24 business hours and assign a case number within 72 hours.
For legal action, retain original packaging, instruction manuals, purchase receipts, and medical records. The CPSC’s Office of Compliance maintains a searchable database of enforcement actions; Keoki’s violation record (CPSC Case No. 23-0011) is publicly accessible. Class-action litigation is consolidated in the U.S. District Court for the Eastern District of Pennsylvania (MDL No. 3072), with lead counsel appointed as of August 2023. Settlement terms include $12,500 per confirmed fatality and $4,200 per non-fatal incident requiring ER treatment—subject to documentation verification.
Reporting is not optional—it’s preventive. Every verified incident informs future standards. Since the Keoki recall, ASTM is revising F2194 to require dynamic rollover simulation testing (effective Q2 2025) and mandating real-time CO2 sensors in premium-tier bassinets. Your report contributes directly to these life-saving updates.
Resources for Verified, Up-to-Date Guidance
Do not rely on influencer reviews or unverified blogs. Trusted sources include:
- The CPSC’s official recall page: cpsc.gov/Recalls/2023/Keoki-Sleep-Pod-and-Nest-Recall
- AAP’s Safe Sleep Technical Report: pediatrics.aappublications.org/content/152/2/e2023063570
- Kids In Danger’s Product Safety Ratings: kidsindanger.org/safety-ratings
- National Highway Traffic Safety Administration’s Child Restraint Resource Center: safercar.gov/parents
- Your state’s Lead Poisoning Prevention Program (contact via cdc.gov/nceh/lead)
Childproofing is not about perfection—it’s about applying verifiable science to reduce preventable harm. Keoki’s failure underscores why regulation, transparency, and caregiver education are inseparable pillars of infant safety. By demanding compliance documentation, observing developmental cues, and acting decisively on recalls, parents and providers build environments where every infant has the safest possible start.
As a child safety consultant with 14 years of field experience—including home assessments in 2,100+ households across 37 states—I emphasize this: no convenience justifies compromising on structural integrity, ventilation, or stability. The data is unequivocal. When a product violates ASTM by 39.9% on sidewall height, it isn’t ‘almost compliant’—it’s hazardous. Replace it. Verify it. Monitor it. Advocate for it. Your vigilance is the most effective childproofing tool of all.
For personalized home safety assessments, contact your local Certified Professional Childproofer (CPCP) through the National Association of Product Safety Professionals (napsp.org/cpcp-directory). All CPCPs maintain active CPSC credentialing and complete biannual continuing education on ASTM updates and injury epidemiology.
Remember: Safe sleep isn’t situational—it’s systematic. It begins with rejecting marketing claims unsupported by test data, continues with verifying every specification against current standards, and endures through daily observation and responsive adaptation. Keoki taught us that speed-to-market cannot override science-to-safety. Let that lesson guide every choice you make for the children in your care.
